A Phase 1B Study of RP1 in Transplant Patients With Advanced Cutaneous Squamous Cell Carcinoma
a study on Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma Carcinoma Carcinoma, Squamous Cell RP1, intra-tumoral injection, oncolytic virus
Lead Scientists at UC Cancer
- Gregory Daniels, MD (ucsd)
Dr. Daniels coordinates our clinical program in melanoma. His own research involves understanding the link between autoimmunity and tumor immunity in developing more effective and less toxic vaccines and immune stimulatory approaches for patients with melanoma.
- Wanxing Chai-Ho, MD (ucla)
HS Assistant Clinical Professor, Medicine.
- Katy Tsai, MD (ucsf)
Dr. Katy K. Tsai is a medical oncologist and clinical researcher who specializes in treating advanced melanoma and other non-melanoma skin cancers, such as squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Dr. Tsai graduated with a degree in comparative literature from Brown University before earning her medical degree from Brown.
- accepting new patients
- Start Date
- Completion Date
- Replimune Inc.
- Phase 1
- Study Type
- Last Updated